A method for preparing acellular allogeneic dermal matrix (ADM) and if
s effectiveness as a dermal substitute are described. Treatment of rat
skin with Dispase followed by Triton X-100 completely removed cellula
r components from the dermis. Subcutaneously implanted ADM evoked no i
mmunological reaction and 20 weeks after implantation, the size of the
implanted ADM was reduced to about 60 per cent of its original area.
ADM became completely vascularized within 2 weeks after implantation i
nto full thickness skin defects in the rat and inhibited extensive wou
nd contracture. A second layer of ADM placed onto the implanted ADM se
rved as an excellent dressing, providing mechanical protection and per
mitting vascularization of the underlying implant. Onlay skin autograf
ts placed onto vascularized allogeneic ADM showed good survival when t
he skin was grafted more than I week after ADM implantation. Dispase/d
etergent treated ADM derived front animal or human skin may be useful
in fall thickness skin defects providing a vascularized bed for subseq
uent epidermal coverage.